Neoadjuvant Endocrine Therapy in Breast Cancer

preview_player
Показать описание

Time stamps:
0:00 - Introduction
1:43 - NET vs Chemotherapy
6:15 - AI vs Tamoxifen
9:05 - Selecting patients for NET
10:30 - Ki67 as marker
13:13 - PEPI score
15:05 - PEPI-P score
15:45 - MammaPrint and BluePrint
21:05 - Duration of treatment
34:10 - Using NET in Practice
40:00 - Q&A
  1. Dr Ettienne
  2. Neoadjuvant Endocrine Therapy
  3. Breast Cancer
  4. Hormone Receptor
  5. HER2
  6. Chemotherapy
Рекомендации по теме
Challenges With Neoadjuvant 0:02:33

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Holmes on 0:01:36

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Ellis on 0:01:25

Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer

Dr. Judy Boughey 0:01:55

Dr. Judy Boughey on Neoadjuvant Endocrine Therapy in Breast Cancer

Evaluating the Role 0:01:47

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Khong on 0:00:54

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Neoadjuvant Endocrine Therapy 0:57:06

Neoadjuvant Endocrine Therapy in Breast Cancer

ALTERNATE: neoadjuvant endocrine 0:03:44

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

Neoadjuvant hormonal treatment 0:07:01

Neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome

Neoadjuvant Therapy for 0:09:36

Neoadjuvant Therapy for HR+ Breast Cancer

Exploring Neoadjuvant Therapy 0:10:05

Exploring Neoadjuvant Therapy for Breast Cancer: What You Need to Know

Dr. Ingrid Mayer 0:05:56

Dr. Ingrid Mayer discusses neoadjuvant endocrine therapy

Dr. Mamounas on 0:01:04

Dr. Mamounas on Adjuvant Endocrine Therapy for Breast Cancer

Treating ER+ breast 0:01:27

Treating ER+ breast cancer patients with endocrine therapy resistance

Neoadjuvant Therapy in 0:07:46

Neoadjuvant Therapy in Breast Cancer | Dr. Rashmi Vaidya

Adjuvant/Neoadjuvant Therapy for 0:38:22

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Updates in Systemic 0:43:14

Updates in Systemic Therapy for Breast Cancer 2/8/23

Exploring Adjuvant Endocrine 0:02:05

Exploring Adjuvant Endocrine Therapy in the Breast Cancer Setting

Endocrine therapy in 0:08:18

Endocrine therapy in premenopausal women with HR+ breast cancer

Optimizing adjuvant treatment 0:01:56

Optimizing adjuvant treatment in HR+/HER2- early breast cancer

CDK4/6 Inhibitors & 0:04:17

CDK4/6 Inhibitors & Endocrine Therapy in Breast Cancer

Neoadjuvant Endocrine Therapy 1:05:36

Neoadjuvant Endocrine Therapy for Breast Cancer, Iván Maldonado-Noboa, M.D.

Adjuvant endocrine therapy 0:06:09

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

ALTERNATE: neoadjuvant chemotherapy 0:03:01

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

Комментарии
Автор

Heavily underutilized compared to chemo, and yet so much less harsh. More women need to know about this.

QuixoticBlackCat
Автор

I’m 40 years old diagnosed with stage one Invasive Ductal Carcinoma. I am pre-menopausal. My oncologist put me on Lupron to stop my ovaries from working and prescribed Anastrazole daily 1mg. Will continue on this therapy for 6 months and see if tumor shrinks. No chemo, surgery or radiation is recommended at this time. We will see at the end of the 6 months. I am ER/PR positive Her2 low.

mbyers